Alliqua BioMedical Stock Price, News & Analysis (NASDAQ:ALQA)

$2.15 -0.10 (-4.44 %)
(As of 11/21/2017 04:00 PM ET)
Previous Close$2.25
Today's Range$2.11 - $2.36
52-Week Range$1.99 - $8.50
Volume49,822 shs
Average Volume57,250 shs
Market Capitalization$11.57 million
P/E RatioN/A
Dividend YieldN/A
Beta1.96

About Alliqua BioMedical (NASDAQ:ALQA)

Alliqua BioMedical logoAlliqua BioMedical, Inc. is a provider of advanced wound care solutions. The Company's businesses include advanced wound care and contract manufacturing. The Company operates through its subsidiaries, such as AquaMed Technologies, Inc. and Choice Therapeutics, Inc. The Company is engaged in developing a suite of advanced wound care solutions that will enable surgeons, clinicians and wound care practitioners to address the challenges in chronic and acute wounds. The Company utilizes hydrogel technology through which hydrogels are manufactured by introducing a hydrophilic polymer into water to create a feed mix. The Company's commercial wound care portfolio consists of over four product categories, such as Human Biologics; Antimicrobial Protection; Exudate Management and Contract Manufacturing. Human Biologics include BIOVANCE and Extracellular Matrix (ECM). Under Antimicrobial Protection, the Company offers SilverSeal.


Industry, Sector and Symbol:
  • Industry: Medical Equipment, Supplies & Distribution
  • Sub-Industry: N/A
  • Sector: Healthcare
  • Symbol: NASDAQ:ALQA
  • CUSIP: N/A
  • Web: alliqua.com
Debt:
  • Current Ratio: 0.47%
  • Quick Ratio: 0.35%
Sales & Book Value:
  • Annual Sales: $18.24 million
  • Price / Sales: 0.59
  • Book Value: $10.81 per share
  • Price / Book: 0.20
Profitability:
  • Trailing EPS: ($9.63)
  • Net Income: $-28,240,000.00
  • Net Margins: -155.55%
  • Return on Equity: -110.42%
  • Return on Assets: -65.28%
Misc:
  • Employees: 81
  • Outstanding Shares: 4,990,000
 

Frequently Asked Questions for Alliqua BioMedical (NASDAQ:ALQA)

What is Alliqua BioMedical's stock symbol?

Alliqua BioMedical trades on the NASDAQ under the ticker symbol "ALQA."

When did Alliqua BioMedical's stock split? How did Alliqua BioMedical's stock split work?

Alliqua BioMedical's stock reverse split on Friday, October 6th 2017. The 1-10 reverse split was announced on Thursday, October 5th 2017. The number of shares owned by shareholders was adjusted after the market closes on Thursday, October 5th 2017. An investor that had 100 shares of Alliqua BioMedical stock prior to the reverse split would have 10 shares after the split.

How were Alliqua BioMedical's earnings last quarter?

Alliqua BioMedical, Inc. (NASDAQ:ALQA) announced its earnings results on Tuesday, August, 9th. The company reported $0.50 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($2.70) by $3.20. The company earned $5.50 million during the quarter, compared to analyst estimates of $5.38 million. Alliqua BioMedical had a negative net margin of 155.55% and a negative return on equity of 110.42%. View Alliqua BioMedical's Earnings History.

Where is Alliqua BioMedical's stock going? Where will Alliqua BioMedical's stock price be in 2017?

3 equities research analysts have issued 1-year price targets for Alliqua BioMedical's stock. Their predictions range from $12.50 to $15.00. On average, they expect Alliqua BioMedical's stock price to reach $14.17 in the next year. View Analyst Ratings for Alliqua BioMedical.

Who are some of Alliqua BioMedical's key competitors?

Who are Alliqua BioMedical's key executives?

Alliqua BioMedical's management team includes the folowing people:

  • Jerome B. Zeldis M.D. Ph.D., Chairman of the Board (Age 67)
  • David Ian Johnson, President, Chief Executive Officer, Director (Age 58)
  • Brian M. Posner CPA, Chief Financial Officer, Treasurer, Secretary (Age 53)
  • Bradford Barton, Chief Operating Officer (Age 55)
  • Nino Pionati, Chief Strategy & Marketing Officer
  • Winston Kung, Director (Age 40)
  • Gary C. Restani, Director (Age 68)
  • Mark T. Wagner, Director
  • Joseph M. Leone, Independent Director (Age 61)
  • Jeffrey Sklar M.D., Independent Director (Age 52)

How do I buy Alliqua BioMedical stock?

Shares of Alliqua BioMedical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Alliqua BioMedical's stock price today?

One share of Alliqua BioMedical stock can currently be purchased for approximately $2.15.

How big of a company is Alliqua BioMedical?

Alliqua BioMedical has a market capitalization of $11.57 million and generates $18.24 million in revenue each year. The company earns $-28,240,000.00 in net income (profit) each year or ($9.63) on an earnings per share basis. Alliqua BioMedical employs 81 workers across the globe.

How can I contact Alliqua BioMedical?

Alliqua BioMedical's mailing address is 1010 Stony Hill Rd Ste 200, YARDLEY, PA 19067-5545, United States. The company can be reached via phone at +1-215-7028550 or via email at [email protected]


MarketBeat Community Rating for Alliqua BioMedical (NASDAQ ALQA)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  175 (Vote Outperform)
Underperform Votes:  101 (Vote Underperform)
Total Votes:  276
MarketBeat's community ratings are surveys of what our community members think about Alliqua BioMedical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Alliqua BioMedical (NASDAQ:ALQA)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 0 Hold Ratings, 3 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $14.17 (558.91% upside)

Consensus Price Target History for Alliqua BioMedical (NASDAQ:ALQA)

Price Target History for Alliqua BioMedical (NASDAQ:ALQA)

Analysts' Ratings History for Alliqua BioMedical (NASDAQ:ALQA)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/18/2017HC WainwrightReiterated RatingBuy$15.00LowView Rating Details
4/11/2017Cowen and CompanyReiterated RatingOutperform$15.00LowView Rating Details
3/8/2017Chardan CapitalLower Price TargetBuy -> Buy$20.00 -> $12.50HighView Rating Details
2/26/2016Northland SecuritiesLower Price TargetOutperform$70.00 -> $30.00N/AView Rating Details
2/26/2016Craig HallumLower Price TargetBuy$30.00N/AView Rating Details
2/24/2016Royal Bank Of CanadaLower Price TargetOutperform$60.00 -> $30.00N/AView Rating Details
(Data available from 11/21/2015 forward)

Earnings

Earnings History and Estimates Chart for Alliqua BioMedical (NASDAQ:ALQA)

Earnings by Quarter for Alliqua BioMedical (NASDAQ:ALQA)

Earnings History by Quarter for Alliqua BioMedical (NASDAQ ALQA)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/10/2017Q2 2017($1.40)($0.90)$5.01 million$5.52 millionViewN/AView Earnings Details
5/9/2017Q1 2017($1.30)($1.70)$4.62 million$4.59 millionViewListenView Earnings Details
3/7/2017Q4 2016($1.90)($1.80)$5.18 million$4.94 millionViewListenView Earnings Details
11/4/2016Q3 2016($2.40)($2.00)$4.85 million$4.87 millionViewN/AView Earnings Details
8/9/2016Q216($2.70)$0.50$5.38 million$5.50 millionViewN/AView Earnings Details
5/10/2016Q116($2.50)($2.80)$4.99 million$4.60 millionViewListenView Earnings Details
2/23/2016Q4($2.80)($1.80)$5.30 million$4.80 millionViewListenView Earnings Details
11/5/2015Q315($2.90)($2.50)$5.44 million$5.00 millionViewN/AView Earnings Details
8/6/2015Q215($3.00)($2.70)$2.85 million$3.10 millionViewN/AView Earnings Details
5/14/2015Q115($3.40)($3.40)$2.37 million$2.10 millionViewListenView Earnings Details
2/24/2015Q414($3.10)($3.40)$1.77 million$1.66 millionViewN/AView Earnings Details
10/30/2014Q3 14($3.10)($3.30)$1.49 millionViewN/AView Earnings Details
3/24/2014Q313($2.30)($16.80)$0.40 million$0.47 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Alliqua BioMedical (NASDAQ:ALQA)
2017 EPS Consensus Estimate: ($0.52)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171($0.16)($0.16)($0.16)
Q2 20171($0.15)($0.15)($0.15)
Q3 20171($0.11)($0.11)($0.11)
Q4 20171($0.10)($0.10)($0.10)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Alliqua BioMedical (NASDAQ:ALQA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Alliqua BioMedical (NASDAQ ALQA)

Insider Ownership Percentage: 15.80%
Insider Trades by Quarter for Alliqua BioMedical (NASDAQ:ALQA)
Institutional Ownership by Quarter for Alliqua BioMedical (NASDAQ:ALQA)

Insider Trades by Quarter for Alliqua BioMedical (NASDAQ ALQA)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/3/2017Bradford BartonCOOBuy75,000$0.40$30,000.00View SEC Filing  
4/3/2017David Ian JohnsonInsiderBuy250,000$0.40$100,000.00View SEC Filing  
4/3/2017Mark T WagnerDirectorBuy62,500$0.40$25,000.00View SEC Filing  
2/27/2017Corp /De/ CelgeneMajor ShareholderBuy4,000,000$0.50$2,000,000.00View SEC Filing  
2/27/2017Jerome B ZeldisDirectorBuy400,000$0.50$200,000.00View SEC Filing  
11/9/2015Brian M PosnerCFOBuy5,000$3.04$15,200.00View SEC Filing  
11/6/2015Bradford BartonCOOBuy5,000$2.97$14,850.00View SEC Filing  
11/6/2015David Ian JohnsonCEOBuy8,650$2.92$25,258.00View SEC Filing  
11/6/2015Jerome B ZeldisDirectorBuy14,000$2.91$40,740.00View SEC Filing  
11/6/2015Pellegrino PionatiInsiderBuy10,000$2.95$29,500.00View SEC Filing  
8/10/2015Brian M PosnerCFOBuy2,500$5.02$12,550.00View SEC Filing  
6/8/2015Bradford BartonCOOBuy3,000$5.25$15,750.00View SEC Filing  
5/27/2015David Ian JohnsonCEOBuy10,000$4.65$46,500.00View SEC Filing  
5/20/2015Brian M PosnerCFOBuy2,500$4.34$10,850.00View SEC Filing  
5/4/2015Corp /De/ CelgeneMajor ShareholderBuy659,340$4.55$2,999,997.00View SEC Filing  
9/15/2014Brian M PosnerCFOBuy2,000$4.94$9,880.00View SEC Filing  
5/13/2014Brian M PosnerCFOBuy3,000$6.92$20,760.00View SEC Filing  
4/14/2014Corp /De/ CelgeneMajor ShareholderBuy714,286$7.00$5,000,002.00View SEC Filing  
5/21/2013Kenneth L LondonerDirectorBuy219,500$0.07$15,365.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Alliqua BioMedical (NASDAQ ALQA)

Source:
DateHeadline
Alliqua BioMedical, Inc. (ALQA) Expected to Post Quarterly Sales of $5.16 MillionAlliqua BioMedical, Inc. (ALQA) Expected to Post Quarterly Sales of $5.16 Million
www.americanbankingnews.com - November 17 at 11:08 AM
40 Biggest Movers From Yesterday | Benzinga - Benzinga40 Biggest Movers From Yesterday | Benzinga - Benzinga
www.benzinga.com - November 16 at 11:03 AM
Alliqua BioMedical, Inc. (ALQA) Expected to Announce Earnings of -$0.70 Per ShareAlliqua BioMedical, Inc. (ALQA) Expected to Announce Earnings of -$0.70 Per Share
www.americanbankingnews.com - November 15 at 9:47 AM
Alliqua BioMedical (ALQA) vs. Its Rivals Critical AnalysisAlliqua BioMedical (ALQA) vs. Its Rivals Critical Analysis
www.americanbankingnews.com - November 13 at 9:16 PM
Edited Transcript of ALQA earnings conference call or presentation 9-Nov-17 1:00pm GMTEdited Transcript of ALQA earnings conference call or presentation 9-Nov-17 1:00pm GMT
finance.yahoo.com - November 10 at 2:28 PM
Alliqua BioMedicals (ALQA) CEO David Johnson on Q3 2017 Results - Earnings Call Transcript - Seeking AlphaAlliqua BioMedical's (ALQA) CEO David Johnson on Q3 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - November 9 at 4:47 PM
Alliqua, Inc. to Host Earnings CallAlliqua, Inc. to Host Earnings Call
finance.yahoo.com - November 9 at 4:47 PM
Alliqua BioMedical, Inc. Engages Cowen to Assist in Evaluating Potential Strategic AlternativesAlliqua BioMedical, Inc. Engages Cowen to Assist in Evaluating Potential Strategic Alternatives
finance.yahoo.com - November 9 at 4:47 PM
Alliqua BioMedical, Inc. Reports Third Quarter of Fiscal Year 2017 Financial Results and Increases Fiscal Year 2017 Financial OutlookAlliqua BioMedical, Inc. Reports Third Quarter of Fiscal Year 2017 Financial Results and Increases Fiscal Year 2017 Financial Outlook
finance.yahoo.com - November 9 at 4:47 PM
Alliqua reports 3Q lossAlliqua reports 3Q loss
finance.yahoo.com - November 9 at 4:47 PM
Head-To-Head Comparison: Alliqua BioMedical (ALQA) vs. Its CompetitorsHead-To-Head Comparison: Alliqua BioMedical (ALQA) vs. Its Competitors
www.americanbankingnews.com - November 8 at 3:56 PM
Alliqua BioMedical (ALQA) & T2 Biosystems (TTOO) Head to Head ComparisonAlliqua BioMedical (ALQA) & T2 Biosystems (TTOO) Head to Head Comparison
www.americanbankingnews.com - November 8 at 5:28 AM
Reviewing Alliqua BioMedical (ALQA) and Sientra (SIEN)Reviewing Alliqua BioMedical (ALQA) and Sientra (SIEN)
www.americanbankingnews.com - November 4 at 11:59 AM
Reviewing Alliqua BioMedical (ALQA) & Its PeersReviewing Alliqua BioMedical (ALQA) & Its Peers
www.americanbankingnews.com - October 31 at 11:10 PM
Alliqua BioMedical, Inc. to Announce Third Quarter of Fiscal Year 2017 Results on November 9th - GlobeNewswire (press release)Alliqua BioMedical, Inc. to Announce Third Quarter of Fiscal Year 2017 Results on November 9th - GlobeNewswire (press release)
globenewswire.com - October 30 at 4:41 PM
Alliqua BioMedical, Inc. to Announce Third Quarter of Fiscal Year 2017 Results on November 9thAlliqua BioMedical, Inc. to Announce Third Quarter of Fiscal Year 2017 Results on November 9th
finance.yahoo.com - October 30 at 4:41 PM
Reviewing Alliqua BioMedical (ALQA) & The CompetitionReviewing Alliqua BioMedical (ALQA) & The Competition
www.americanbankingnews.com - October 22 at 10:10 AM
Is It Time To Buy Alliqua BioMedical Inc (ALQA)?Is It Time To Buy Alliqua BioMedical Inc (ALQA)?
finance.yahoo.com - October 17 at 9:39 PM
Alliqua BioMedical, Inc. (ALQA) Expected to Post Quarterly Sales of $4.98 MillionAlliqua BioMedical, Inc. (ALQA) Expected to Post Quarterly Sales of $4.98 Million
www.americanbankingnews.com - October 8 at 1:04 AM
Alliqua BioMedical, Inc. (ALQA) Upgraded at ValuEngineAlliqua BioMedical, Inc. (ALQA) Upgraded at ValuEngine
www.americanbankingnews.com - October 6 at 11:14 PM
 Brokerages Expect Alliqua BioMedical, Inc. (ALQA) to Post -$0.08 EPS Brokerages Expect Alliqua BioMedical, Inc. (ALQA) to Post -$0.08 EPS
www.americanbankingnews.com - October 6 at 10:30 PM
Alliqua BioMedical, Inc. Announces 1-for-10 Reverse Stock Split - GlobeNewswire (press release)Alliqua BioMedical, Inc. Announces 1-for-10 Reverse Stock Split - GlobeNewswire (press release)
globenewswire.com - October 5 at 6:13 PM
Alliqua BioMedical, Inc. Announces 1-for-10 Reverse Stock SplitAlliqua BioMedical, Inc. Announces 1-for-10 Reverse Stock Split
finance.yahoo.com - October 5 at 6:13 PM
Have Investors Already Priced In Alliqua BioMedical Inc’s (ALQA) Growth?Have Investors Already Priced In Alliqua BioMedical Inc’s (ALQA) Growth?
finance.yahoo.com - September 22 at 2:43 PM
AtriCure (ATRC) versus Alliqua BioMedical (ALQA) Financial ComparisonAtriCure (ATRC) versus Alliqua BioMedical (ALQA) Financial Comparison
www.americanbankingnews.com - September 19 at 6:10 PM
Alliqua BioMedicals (ALQA) "Buy" Rating Reiterated at HC WainwrightAlliqua BioMedical's (ALQA) "Buy" Rating Reiterated at HC Wainwright
www.americanbankingnews.com - September 18 at 10:16 PM
 Analysts Expect Alliqua BioMedical, Inc. (ALQA) Will Announce Earnings of -$0.12 Per Share Analysts Expect Alliqua BioMedical, Inc. (ALQA) Will Announce Earnings of -$0.12 Per Share
www.americanbankingnews.com - September 18 at 4:24 AM
Featured Company News - Pfizer Receives Warning Letter from FDA Highlighting Manufacturing Defects in the EpiPen Administered for AnaphylaxisFeatured Company News - Pfizer Receives Warning Letter from FDA Highlighting Manufacturing Defects in the EpiPen Administered for Anaphylaxis
finance.yahoo.com - September 11 at 4:36 PM
Alliqua BioMedical, Inc. Announces the Sale of TheraBond® 3D Antimicrobial Barrier Systems Product Line; Alliqua ... - GlobeNewswire (press release)Alliqua BioMedical, Inc. Announces the Sale of TheraBond® 3D Antimicrobial Barrier Systems Product Line; Alliqua ... - GlobeNewswire (press release)
globenewswire.com - September 5 at 11:04 PM
[$$] The Add-On Deal Roundup: Sept. 5[$$] The Add-On Deal Roundup: Sept. 5
finance.yahoo.com - September 5 at 11:03 PM
ETFs with exposure to Alliqua BioMedical, Inc. : September 5, 2017ETFs with exposure to Alliqua BioMedical, Inc. : September 5, 2017
finance.yahoo.com - September 5 at 11:03 PM
Alliqua (ALQA) Sells TheraBond 3D Antimicrobial Barrier Systems Product Line; Updates OutlookAlliqua (ALQA) Sells TheraBond 3D Antimicrobial Barrier Systems Product Line; Updates Outlook
www.streetinsider.com - September 5 at 5:25 PM
Alliqua BioMedical, Inc. Announces the Sale of TheraBond® 3D Antimicrobial Barrier Systems Product Line; Alliqua Updates Fiscal Year OutlookAlliqua BioMedical, Inc. Announces the Sale of TheraBond® 3D Antimicrobial Barrier Systems Product Line; Alliqua Updates Fiscal Year Outlook
finance.yahoo.com - September 5 at 5:25 PM
Contrasting Alliqua BioMedical (ALQA) and Tandem Diabetes Care (TNDM)Contrasting Alliqua BioMedical (ALQA) and Tandem Diabetes Care (TNDM)
www.americanbankingnews.com - September 4 at 10:18 AM
$5.37 Million in Sales Expected for Alliqua BioMedical, Inc. (ALQA) This Quarter$5.37 Million in Sales Expected for Alliqua BioMedical, Inc. (ALQA) This Quarter
www.americanbankingnews.com - September 1 at 3:48 AM
-$0.12 EPS Expected for Alliqua BioMedical, Inc. (ALQA) This Quarter-$0.12 EPS Expected for Alliqua BioMedical, Inc. (ALQA) This Quarter
www.americanbankingnews.com - August 30 at 4:24 PM
Alliqua BioMedical, Inc. :ALQA-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017Alliqua BioMedical, Inc. :ALQA-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017
finance.yahoo.com - August 25 at 5:21 PM
HC Wainwright Reiterates "$2.00" Price Target for Alliqua BioMedical, Inc. (ALQA)HC Wainwright Reiterates "$2.00" Price Target for Alliqua BioMedical, Inc. (ALQA)
www.americanbankingnews.com - August 13 at 3:32 PM
-$0.12 EPS Expected for Alliqua BioMedical, Inc. (NASDAQ:ALQA) This Quarter-$0.12 EPS Expected for Alliqua BioMedical, Inc. (NASDAQ:ALQA) This Quarter
www.americanbankingnews.com - August 12 at 6:12 AM
Edited Transcript of ALQA earnings conference call or presentation 10-Aug-17 12:00pm GMTEdited Transcript of ALQA earnings conference call or presentation 10-Aug-17 12:00pm GMT
finance.yahoo.com - August 10 at 10:13 PM
Alliqua BioMedical, Inc. Reports Second Quarter of Fiscal Year 2017 Financial Results - GlobeNewswire (press release)Alliqua BioMedical, Inc. Reports Second Quarter of Fiscal Year 2017 Financial Results - GlobeNewswire (press release)
globenewswire.com - August 10 at 5:10 PM
Alliqua BioMedical, Inc. Reports Second Quarter of Fiscal Year 2017 Financial ResultsAlliqua BioMedical, Inc. Reports Second Quarter of Fiscal Year 2017 Financial Results
finance.yahoo.com - August 10 at 5:10 PM
Alliqua reports 2Q lossAlliqua reports 2Q loss
finance.yahoo.com - August 10 at 5:10 PM
Alliqua BioMedical, Inc. (ALQA) Posts Quarterly  Earnings Results, Beats Expectations By $0.05 EPSAlliqua BioMedical, Inc. (ALQA) Posts Quarterly Earnings Results, Beats Expectations By $0.05 EPS
www.americanbankingnews.com - August 10 at 3:42 PM
Alliqua BioMedical, Inc. (ALQA) Set to Announce Earnings on MondayAlliqua BioMedical, Inc. (ALQA) Set to Announce Earnings on Monday
www.americanbankingnews.com - July 31 at 8:05 AM
Alliqua BioMedical, Inc. to Announce Second Quarter of Fiscal Year ... - NasdaqAlliqua BioMedical, Inc. to Announce Second Quarter of Fiscal Year ... - Nasdaq
www.nasdaq.com - July 26 at 3:53 PM
Alliqua BioMedical, Inc. to Announce Second Quarter of Fiscal Year 2017 Results on August 10thAlliqua BioMedical, Inc. to Announce Second Quarter of Fiscal Year 2017 Results on August 10th
finance.yahoo.com - July 26 at 3:52 PM
 Analysts Expect Alliqua BioMedical, Inc. (ALQA) Will Post Earnings of -$0.14 Per Share Analysts Expect Alliqua BioMedical, Inc. (ALQA) Will Post Earnings of -$0.14 Per Share
www.americanbankingnews.com - July 25 at 10:41 AM
Head-To-Head Comparison: DENTSPLY SIRONA (XRAY) versus Alliqua BioMedical (NASDAQ:ALQA)Head-To-Head Comparison: DENTSPLY SIRONA (XRAY) versus Alliqua BioMedical (NASDAQ:ALQA)
www.americanbankingnews.com - July 16 at 2:11 PM
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Alliqua BioMedical, Inc. for Potential Breaches ... - PR Newswire (press release)SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Alliqua BioMedical, Inc. for Potential Breaches ... - PR Newswire (press release)
www.prnewswire.com - June 22 at 3:29 PM

Social Media

Financials

Chart

Alliqua BioMedical (NASDAQ ALQA) Chart for Tuesday, November, 21, 2017
Loading chart…

This page was last updated on 11/21/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.